Musculoskeletal Disorders Treatment Market Size to Reach USD 326.26 Bn by 2032

The global musculoskeletal disorders treatment market size is calculated at USD 192.88 billion in 2024 and is expected to reach around USD 326.26 billion by 2032, growing at a CAGR of 6% from 2024 to 2032.

/EIN News/ -- Ottawa, July 17, 2024 (GLOBE NEWSWIRE) -- The global musculoskeletal disorders treatment market size was valued at USD 186.02 billion in 2023 and is predicted to hit around USD 326.26 billion by 2032, a study published by Towards Healthcare a sister firm of Precedence Statistics.

Download a short version of this report @ https://www.towardshealthcare.com/personalized-scope/5148

Key Takeaways

• North America reported being the largest region, with a 37% market share in 2023.
• The osteoarthritis segment dominated the type segment with a 33% market share in 2023.
• Medications took the charge, with over 60% of the market share in 2023.
  

Musculoskeletal Disorders Treatment Market at a Glance

The musculoskeletal disorders treatment market encompasses the products and services designed to diagnose, manage, and treat conditions affecting the musculoskeletal system, which includes bones, muscles, tendons, ligaments, and other connective tissues. These disorders can significantly impact a person's mobility and quality of life, and the market for their treatment is diverse and continually evolving.

Musculoskeletal disorders (MSDs) are injuries that affect the muscles, bones, joints, cartilage, connective tissue, and tendons. MSDs are caused by continuously sitting in a place, lifting heavy weights daily, aging, bone fractures, and joint dislocation. The symptoms of MSD include muscle pain and strain, stiffness, tingling, numbness, and swelling. The different types of MSDs include osteoarthritis, rheumatoid arthritis, osteoporosis, hernia, carpal tunnel syndrome, and sarcopenia, out of which osteoarthritis is the most common.

• According to the WHO Report 2022, nearly 1.7 billion people worldwide were reported with MSDs. The common treatments for MSD include NSAIDs, physical exercises, acupuncture, hot and cold therapy, and steroids. The musculoskeletal disorders market is potentiated by the increasing elderly population, increasing awareness among individuals in preventing and treating the disorder, and advanced treatment options
  

Regional Insights:

North America led the musculoskeletal disorders treatment market in 2023. The region is observed to sustain the position during the forecast period. North America region shows the highest potential for the musculoskeletal disorder market to grow while the United States and Canada become the largest contributors to the market. Countries like the US and Canada report a high prevalence of MSDs globally. The market growth potential in this region is due to the increasing prevalence of MSDs due to obesity and unhealthy lifestyles of individuals, rising awareness, and advanced treatment alternatives.

• The American Academy of Orthopaedic Surgeons (AAOS) highlighted the significance of orthobiologics, a regenerative medicine, for treating osteoarthritis. They also presumed orthobiologics to be the future treatment alternative for MSD patients, however, a more detailed investigation is required.
  

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

Europe region also has the potential to drive the MSD treatment market. Work-related MSDs are the most common health problem in European countries, resulting in reduced productivity in the countries. According to a survey, 46% of individuals in Europe reported back pain whereas 43% of individuals reported shoulder and neck pain. The rise in advanced research and development and government initiatives for increasing awareness among individuals can boost the market growth potential. European pharmaceutical companies are at the forefront of finding solutions for treating chronic MSDs.

• In October 2023, the USFDA approved a novel drug, Bimzelx, for the treatment of psoriatic arthritis, developed by a Belgian pharmaceutical company UCB. Bimzelx is a monoclonal antibody that can improve joint function and mobility.
  

On the other hand, Asia Pacific is observed to grow at the fastest rate in the musculoskeletal disorders treatment market during the forecast period. The market is observed to expand due to rising cases of MSDs, an increasing elderly population, advanced healthcare facilities, and state-of-the-art research and development. Additionally, traditional medicines and treatment options like acupuncture uplift the MSD treatment market in countries like China, India, and Japan. Advances in medical technology, increased awareness, and an aging global population are key drivers propelling the market forward. However, challenges such as high costs and regulatory barriers must be addressed to ensure broader access and improved treatment outcomes.

• In March 2024. A Korean startup, EverEx, provided a digital solution for the musculoskeletal disorder, MORA. MORA utilizes AI to generate and analyze patient-related data and suggest rehabilitation exercises.
  

Market Dynamics:

Non-Pharmacological Therapy as a Driver for Musculoskeletal Disorder Treatment Market

The non-pharmacological treatment options prove to be more efficacious than the pharmacological treatments. The non-pharmacological therapies include physical exercises, acupuncture, pulsed electromagnetic field therapy, ultrasound, cryotherapy, heat and cold therapy, and chiropractic adjustments. Strong evidence suggests that these non-pharmacological therapies could help treat MSDs. Although pharmacological (drug) therapy is helpful for musculoskeletal pain, not all patients react to it, and there are significant side effects involved. Hence, pharmacological and non-pharmacological therapies both are used to relieve musculoskeletal pain.

High Treatment Costs can Limit the Market's Growth Potential

The high costs of musculoskeletal disorder diagnosis and treatment can limit the market's growth potential. The exorbitant prices of advanced diagnostic tools like MRIs and CT scans result in the patient’s unaffordability. Furthermore, the high treatment costs foster inappropriate management of MSDs, thereby refraining from root-cause treatment.

Regenerative Therapy as an Opportunity for MusculoSkeletal Disorders Treatment Market

Researchers are currently investigating the significant cell types employed in treatments for degenerative musculoskeletal tissue and applying native or engineered skeletal stem cells directly to resurrect degenerative musculoskeletal tissue, initiating tissue repair and healing. Since endogenous stem cells are present in almost all tissues and support proper homeostatic function, targeted manipulation of the stem cell niche could overcome the microenvironmental cues in the injury or degeneration.

Mesenchymal stem cells (MSCs) have emerging potential in the treatment of musculoskeletal disorders. MSCs are recognized as promising natural cell populations for musculoskeletal regeneration due to their mesodermal origin, immunomodulatory properties, limited tumorigenicity, and robust ability to differentiate into major cell types. However, a deeper understanding of the role of stem cells in musculoskeletal disorders is underway, which can be an opportunity for the musculoskeletal disorders treatment market.

Customize this study as per your requirement @ https://www.towardshealthcare.com/customization/5148

Major Breakthroughs in the Musculoskeletal Disorders Treament Market

• In May 2024, researchers from the University of Birmingham developed a small, novel natural peptide, PEPITEM, to treat age-related musculoskeletal disorders. This peptide increases bone density, bone formation, and strength.
• In September 2023, Venture Lab and Amplicore launched a Phase 1/2 clinical trial of AM3101, an injectable therapeutic for relieving the pain of meniscus tear surgeries.
• In November 2023, researchers from the University of Pennsylvania developed a tension-activated repair patch for targeted drug delivery for disc herniation conditions. The patch gets activated by body motions and releases the drug at the target site.
  

Segmental Insights:

By Type:

The osteoarthritis segment led the musculoskeletal disorders treatment market in 2023. Osteoarthritis is one of the most common chronic joint conditions, affecting millions of people worldwide. As a leading cause of disability, it predominantly affects the elderly population, whose numbers are steadily increasing due to global aging trends. This high prevalence directly translates to a larger market demand for osteoarthritis treatments.

It causes substantial pain, stiffness, and decreased mobility, severely impacting patients' quality of life. This drives individuals to seek effective treatments to manage their symptoms and maintain their daily activities. The substantial need for symptom management ensures a robust demand for various treatment modalities.

Increased awareness campaigns and better diagnostic techniques have led to earlier detection and treatment of osteoarthiritis. Early intervention can significantly slow the progression of the disease, enhancing the effectiveness of treatments and improving patient quality of life, thereby driving market growth.

By Product Type:

The medications segment led the musculoskeletal disorders treatments market in 2023. Medications can be used to treat a variety of musculoskeletal disorders, including arthritis, osteoporosis, back pain, and muscle strains. This broad applicability contributes to the dominance of the medications segment in the market. Medications are generally more accessible than other treatment options. They can be prescribed by general practitioners and do not require specialized equipment or facilities. Patients can easily obtain and use these treatments at home, making them a convenient option. Musculoskeletal disorders often result in significant pain and inflammation, making pain management a primary concern. Medications, particularly analgesics and anti-inflammatory drugs, provide quick and effective relief, which is essential for improving patients' quality of life.

On the other hand, the implants segment is observed to grow at a notable rate in musculoskeletal disorders treatment market during the forecast period. Musculoskeletal disorders, such as osteoarthritis, rheumatoid arthritis, and osteoporosis, often lead to severe joint and bone damage that necessitates surgical intervention. Joint replacements, particularly knee and hip replacements, are common procedures for managing these conditions. The increasing incidence of these disorders drives the demand for orthopedic implants.

By End-user:

The hospitals segment dominated the musculoskeletal disorders treatment market in 2023. The segment is observed to sustain the position during the forecast period. Hospitals offer a multidisciplinary approach to musculoskeletal disorders, integrating the expertise of orthopedic surgeons, rheumatologists, physiotherapists, and pain management specialists. This comprehensive care model ensures patients receive well-rounded and effective treatment plans tailored to their specific needs. Hospitals are equipped with advanced diagnostic tools such as MRI, CT scans, X-rays, and ultrasound machines, which are crucial for accurately diagnosing musculoskeletal disorders. They also house advanced surgical facilities and robotic-assisted surgery systems, enhancing the precision and outcomes of orthopedic surgeries.

Browse More Insights of Towards Healthcare:

1. Cell Separation Market Size to Reach USD 23.56 Bn by 2033
   

The global cell separation market size was estimated at US$ 9.10 billion in 2023 and is projected to grow US$ 23.56 billion by 2033, rising at a compound annual growth rate (CAGR) of 9.98% from 2024 to 2033.

2. Circulating Tumor Cells Market Size to Reach USD 41.27 Bn by 2033

The global circulating tumor cells market size was estimated at US$ 11.49 billion in 2023 and is projected to grow US$ 41.27 billion by 2033, rising at a compound annual growth rate (CAGR) of 13.64% from 2024 to 2033.

1. Protein Labeling Market Size to Reach USD 5.55 Bn by 2033 Report
   

The global protein labeling market size was estimated at US$ 2.46 billion in 2023 and is projected to grow US$ 5.55 billion by 2033, rising at a compound annual growth rate (CAGR) of 8.48% from 2024 to 2033. 

4. The U.S. genotyping market was valued at US$ 6.45 billion in 2023 and is predicted to reach US$ 23.33 billion by the end of 2033, representing an impressive CAGR of 13.72% from 2024 to 2033.

5. The catheter related bloodstream infection market was valued at US$ 1.53 billion in 2023 and is predicted to reach US$ 2.52 billion by the end of 2033, representing an impressive CAGR of 5.13% from 2024 to 2033.

6. The chronic obstructive pulmonary disease market size was valued at US$ 21.6 billion in 2023 and is predicted to reach US$ 33.29 billion by the end of 2033, representing an impressive CAGR of 4.42% from 2024 to 2033.

7. The cancer vaccines market was valued at US$ 10.21 billion in 2023 and is predicted to reach US$ 30.16 billion by the end of 2033, representing an impressive CAGR of 11.44% from 2024 to 2033.

8. The healthcare analytics market size is estimated to grow from 42.90 billion in 2023 to reach around USD 241.16 billion by 2032, registering at a CAGR of 19.1% between 2024 and 2032.

9. The Parkinson’s disease diagnosis and treatment market size is estimated to grow from USD 6.32 billion in 2023 to reach around USD 14.36 billion by 2032, registering at a 8.9% of CAGR between 2024 and 2032.

10. The ambulatory surgical centers market accounted for USD 94.57 billion in 2022 and is predicted to increase to USD 167.1 billion by 2032 and is poised to grow at a CAGR of 5.66% from 2023 to 2032.

Musculoskeletal Disorders Treatment Market Companies

• Johnson & Johnson
• Pfizer
• Novartis
• Abbott Laboratories
• Medtronic
• Stryker Corporation
• Hoffmann-La Roche Ltd.
• Amgen Inc.
• Arthrex, Inc.
• Enovis
• Globus Medical
• NuVasive

Musculoskeletal Disorders Treatment Market Segments

By Type

• Tendonitis
• Osteoarthritis
• Rheumatoid Arthritis
• Carpel Tunnel Syndrome
• Fibromyalgia
• Other Musculoskeletal Disorders

By Product Type

• Medications
  • Pain Relievers
  • Anti-inflammatory Drugs
  • DMARs
  • Other Medications
• Implants
  • Joint Replacement Implants
    • Hip Implants
    • Knee Implants
    • Shoulder Implants
    • Elbow Implants
  • Spinal Implants
  • Fracture Repair Implants
• Prosthetics
• Orthotics
• Braces
• Physical Therapy Equipment
  

By End User

• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Home Care Settings

By Geography

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• South America
  

Acquire our comprehensive analysis today @ https://www.towardshealthcare.com/price/5148

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

Gain access to the latest insights and statistics in the healthcare industry by subscribing to our Annual Membership. Stay updated on healthcare industry segmentation with detailed reports, market trends, and expert analysis tailored to your needs. Stay ahead of the curve with valuable resources and strategic recommendations. Join today to unlock a wealth of knowledge and opportunities in the dynamic world of healthcare: Get a Subscription

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.

Browse our Brand-New Journals:

https://www.towardspackaging.com

https://www.towardsautomotive.com 

https://www.precedenceresearch.com

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

Get Our Freshly Printed Chronicle: https://www.healthcarewebwire.com